ヒト初代細胞培養の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

ヒト初代細胞培養市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のヒト初代細胞培養市場は2030年までに71億5,000万米ドルに達し、2025～2030年のCAGRは11.05％で成長すると予測されています。

1次細胞培養市場の成長は、モノクローナル抗体の需要増加、がん研究イニシアチブの増加、製薬会社やバイオテクノロジー会社の拡大、確立された細胞株に対するヒト1次細胞の利点の増加、細胞ベースの研究に対する政府支援の増加など、いくつかの主要な要因に起因しています。

モノクローナル抗体は、特定の抗原を標的とする高い特異性と有効性により、様々な治療用途の中心的存在となっています。プライマリー細胞は、これらの抗体の開発と検査において重要な役割を果たしており、市場における需要を牽引しています。創薬、毒性検査、疾患モデリング、個別化医療のために初代細胞に大きく依存している製薬・バイオテクノロジー産業もまた、著しい成長を遂げています。精密医療と標的療法へのシフトは、研究開発活動における初代細胞の需要を増幅させ、現代の医療ソリューションの推進に欠かせないものとなっています。

市場を推進しているもう一つの重要な要因は、感染症を研究するためのより効果的なモデルに対する需要の増加です。COVID-19の大流行により、ワクチン候補、抗ウイルス薬、その他の治療法を検査するための正確なモデルの必要性に対する認識が高まっています。ヒト初代細胞培養は、HIV、肝炎、インフルエンザなどの疾患に対する新しいワクチンや治療法の開発に不可欠なヒト組織の反応を忠実に模倣するため、ウイルス感染の研究に特に適しています。さらに、免疫細胞の挙動を再現できることから、免疫応答や宿主と病原体の相互作用を理解する上で不可欠です。

プライマリー細胞は、細胞株よりも生物学的により適切な研究モデルを提供する一方で、その高コストが入手を制限することもあります。ヒト初代細胞の入手には、専門のバイオリポジトリや商業ベンダーからの情報が必要となることが多く、これらの細胞は確立された細胞株よりもかなり高価になる可能性があります。

ヒト初代細胞培養市場レポートハイライト

• 製品別では、初代細胞セグメントが2024年に最大の市場シェアを占めました。個別化医療への需要の高まり、3D培養、臓器オンチッププラットフォーム、マイクロ流体システムなどの技術進歩、創薬や毒性検査への注目の高まりが、このセグメントの成長を牽引しています。
• 用途別では、治療開発セグメントが2024年のシェアで市場を独占しました。初代細胞は、生物製剤、モノクローナル抗体、ワクチンの製造に不可欠です。さらに、パンデミックは、ウイルス学における細胞培養の重要な役割を実証し、持続的な投資を促進しました。
• 最終用途別では、製薬・バイオテクノロジー企業が2024年の市場を独占しました。製薬・バイオ医薬品産業は、創薬・開発・製造のための細胞ベースモデルの採用拡大により、市場の大幅な成長を目の当たりにしています。
• 北米地域は2024年に41.12%の市場シェアを占めました。北米のヒト初代細胞培養産業は、いくつかの重要な要因によって著しい成長を遂げています。主要要因は、がん、糖尿病、心血管障害などの慢性疾患の有病率の増加であり、これが創薬開発に初代細胞培養を利用する研究活動の急増につながっています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 産業分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 ヒト初代細胞培養市場：製品ビジネス分析

• 製品セグメントダッシュボード
• 世界のヒト初代細胞培養市場の製品変動分析
• 世界のヒト初代細胞培養市場の規模と動向分析、製品別、2018～2030年
• 初代細胞
• 初代細胞培養培地
• 試薬とサプリメント

第5章 初代細胞培養市場：用途ビジネス分析

• 用途セグメントダッシュボード
• 世界のヒト初代細胞培養市場の用途変動分析
• 世界のヒト初代細胞培養市場の規模と動向分析、用途別、2018～2030年
• 創薬
• 治療法の開発
• 再生医療
• その他

第6章 初代細胞培養市場：最終用途ビジネス分析

• 最終用途セグメントダッシュボード
• 世界のヒト初代細胞培養市場の最終用途変動分析
• 世界のヒト初代細胞培養市場の規模と動向分析、最終用途別、2018～2030年
• 製薬・バイオテクノロジー企業
• CMOとCRO
• 学術研究機関

第7章 初代細胞培養市場：製品、用途、最終用途による地域別、推定・動向分析

• 地域ダッシュボード
• 市場規模と予測と動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 参入企業
• 戦略マッピング
• 企業市況分析、2024年
• 参入企業概要
  • Thermo Fisher Scientific Inc.
  • STEMCELL Technologies
  • Merck KGaA
  • Lonza
  • Cell Biologics, Inc.
  • PromoCell GMBH
  • ZenBio
  • AllCells
  • American Type Culture Collection
  • Axol Biosciences Ltd.

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 4 Global human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 5 Global human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 6 Global human primary cell culture market , by region, 2018 - 2030 (USD million)
• Table 7 North America human primary cell culture market , by country, 2018 - 2030 (USD million)
• Table 8 North America human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 9 North America human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 10 North America human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 11 U.S. human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 12 U.S. human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 13 U.S. human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 14 Canada human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 15 Canada human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 16 Canada human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 17 Mexico human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 18 Mexico human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 19 Mexico human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 20 Europe human primary cell culture market , by country, 2018 - 2030 (USD million)
• Table 21 Europe human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 22 Europe human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 23 Europe human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 24 UK human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 25 UK human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 26 UK human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 27 Germany human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 28 Germany human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 29 Germany human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 30 France human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 31 France human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 32 France human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 33 Italy human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 34 Italy human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 35 Italy human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 36 Spain human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 37 Spain human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 38 Spain human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 39 Denmark human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 40 Denmark human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 41 Denmark human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 42 Sweden human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 43 Sweden human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 44 Sweden human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 45 Norway human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 46 Norway human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 47 Norway human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 48 Asia Pacific human primary cell culture market , by country, 2018 - 2030 (USD million)
• Table 49 Asia Pacific human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 50 Asia Pacific human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 51 Asia Pacific human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 52 Japan human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 53 Japan human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 54 Japan human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 55 China human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 56 China human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 57 China human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 58 India human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 59 India human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 60 India human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 61 Australia human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 62 Australia human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 63 Australia human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 64 Thailand human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 65 Thailand human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 66 Thailand human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 67 South Korea human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 68 South Korea human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 69 South Korea human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 70 Latin America human primary cell culture market , by country, 2018 - 2030 (USD million)
• Table 71 Latin America human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 72 Latin America human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 73 Latin America human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 74 Brazil human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 75 Brazil human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 76 Brazil human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 77 Argentina human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 78 Argentina human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 79 Argentina human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 80 Middle East & Africa human primary cell culture market , by country, 2018 - 2030 (USD million)
• Table 81 Middle East & Africa human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 82 Middle East & Africa human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 83 Middle East & Africa human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 84 South Africa human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 85 South Africa human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 86 South Africa human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 87 Saudi Arabia human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 88 Saudi Arabia human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 89 Saudi Arabia human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 90 UAE human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 91 UAE human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 92 UAE human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 93 Kuwait human primary cell culture market , by product, 2018 - 2030 (USD million)
• Table 94 Kuwait human primary cell culture market , by application , 2018 - 2030 (USD million)
• Table 95 Kuwait human primary cell culture market , by end use, 2018 - 2030 (USD million)
• Table 96 Participant's overview
• Table 97 Financial performance

List of Figures

• Fig. 1 Human primary cell culture market segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research process
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modelling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market outlook
• Fig. 13 Segment snapshot - 1
• Fig. 14 Segment snapshot - 2
• Fig. 15 Competitive landscape snapshot
• Fig. 16 Cell culture market value, 2023 (USD billion)
• Fig. 17 Market trends & outlook
• Fig. 18 PESTEL analysis
• Fig. 19 Porter's five forces analysis
• Fig. 20 Human primary cell culture market: Product outlook and key takeaways
• Fig. 21 Human primary cell culture market: Product movement analysis
• Fig. 22 Primary cells market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 23 Hematopoietic cells market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 24 Skin cells market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 25 Hepatocytes market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 26 Gastrointestinal cells market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 27 Lung cells market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 28 Renal cells market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 29 Heart cells market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 30 Skeletal & muscle cells market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 31 Other primary cells market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 32 Primary cell culture media market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 33 Serum-free media market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 34 Serum-containing media market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 35 Other market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 36 Reagents & supplements market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 37 Attachment solutions market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 38 Buffers & salts market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 39 Sera market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 40 Growth factors & cytokines market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 42 Human primary cell culture market: Application outlook and key takeaways
• Fig. 43 Human primary cell culture market: Application movement analysis
• Fig. 44 Drug discovery market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 45 Therapy development market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 46 Regenerative medicine market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 47 Others market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 48 Human primary cell culture market: End use outlook & key takeaways
• Fig. 49 Human primary cell culture market: End use, movement analysis
• Fig. 50 Pharmaceutical & biopharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 51 CMOs & CROs market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 52 Academic research institutes market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 53 Regional marketplace outlook, 2024 & 2030 (USD Million)
• Fig. 54 Regional marketplace: Key takeaways
• Fig. 55 North America human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 56 Key country dynamics
• Fig. 57 U.S. human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 58 Key country dynamics
• Fig. 59 Canada human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 60 Key country dynamics
• Fig. 61 Mexico human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 Europe human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 63 Key country dynamics
• Fig. 64 Germany human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 65 Key country dynamics
• Fig. 66 UK human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 67 Key country dynamics
• Fig. 68 France human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 69 Key country dynamics
• Fig. 70 Italy human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 71 Key country dynamics
• Fig. 72 Spain human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 73 Key country dynamics
• Fig. 74 Denmark human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 75 Key country dynamics
• Fig. 76 Sweden human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 77 Key country dynamics
• Fig. 78 Norway human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 79 Asia Pacific human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 Japan human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 China human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 84 Key country dynamics
• Fig. 85 India human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 86 Key country dynamics
• Fig. 87 Australia Human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 88 Key country dynamics
• Fig. 89 Thailand human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 90 Key country dynamics
• Fig. 91 South Korea human primary cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Latin America human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 93 Key country dynamics
• Fig. 94 Brazil human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 95 Key country dynamics
• Fig. 96 Argentina human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 97 MEA human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 98 Key country dynamics
• Fig. 99 South Africa human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 100 Key country dynamics
• Fig. 101 Saudi Arabia human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 102 Key country dynamics
• Fig. 103 UAE human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 104 Key country dynamics
• Fig. 105 Kuwait human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 106 Market participant categorization
• Fig. 107 Global human primary cell culture company position analysis, 2024
• Fig. 108 Strategic framework

Human Primary Cell Culture Market Growth & Trends:

The global human primary cell culture market is anticipated to reach USD 7.15 billion by 2030 and grow at a CAGR of 11.05% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the primary cell culture market can be attributed to several key factors including the increasing demand for monoclonal antibodies, a rise in cancer research initiatives, the expanding number of pharmaceutical and biotechnology companies, the growing advantages of primary human cells over established cell lines, and increased government support for cell-based research.

Monoclonal antibodies have become central to various therapeutic applications due to their high specificity and effectiveness in targeting specific antigens. Primary cells play a critical role in developing and testing these antibodies, driving their demand in the market. The pharmaceutical and biotechnology industries, which rely heavily on primary cells for drug discovery, toxicity testing, disease modeling, and personalized medicine, are also experiencing significant growth. The shift toward precision medicine and targeted therapies has amplified the demand for primary cells in research and development activities, making them indispensable in advancing modern healthcare solutions.

Another significant factor propelling the market is the increasing demand for more effective models to study infectious diseases. The COVID-19 pandemic has heightened awareness around the need for accurate models to test vaccine candidates, antiviral drugs, and other therapeutic solutions. Human primary cell cultures are particularly suited for studying viral infections, as they closely mimic human tissue responses, which is critical in developing new vaccines and treatments for diseases like HIV, hepatitis, and influenza. Additionally, their ability to replicate the behavior of immune cells makes them essential in understanding immune responses and host-pathogen interactions.

While primary cells offer a more biologically relevant model for research than cell lines, their high cost can limit their accessibility. Procuring human primary cells often involves sourcing from specialized biorepositories or commercial vendors, and these cells can be considerably more expensive than established cell lines.

Human Primary Cell Culture Market Report Highlights:

• Based on product, the primary cells segment held the largest market share in 2024. The rising demand for personalized medicine, technological advancements in 3D culture, organ-on-chip platforms, and microfluidic systems, and the rising focus on drug discovery and toxicology testing drive the segment's growth.
• Based on application, the therapy development segment dominated the market with a share in 2024. Primary cells are essential for producing biologics, monoclonal antibodies, and vaccines. Moreover, the pandemic demonstrated the critical role of cell culture in virology, driving sustained investment.
• Based on end use, the pharmaceutical & biotechnology companies segment dominated the market in 2024. The pharmaceutical and biopharmaceutical industries are witnessing substantial growth in the market, driven by the growing adoption of cell-based models for drug discovery, development, and manufacturing.
• The North American region dominated the market share of 41.12% in 2024. North America's human primary cell culture industry is experiencing significant growth, driven by several key factors. A major contributor is the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, which has led to a surge in research activities utilizing primary cell cultures for drug discovery and development.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Type Segment
  • 1.2.3. End Use Segment
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of chronic and infectious diseases
    • 3.2.1.2. Growing focus on personalized medicine
    • 3.2.1.3. Technological innovations in 3D cell culture
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of primary cells
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Human Primary Cell Culture Market: Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Human Primary Cell Culture Market Product Movement Analysis
• 4.3. Global Human primary cell culture market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Primary Cells
  • 4.4.1. Global Primary Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Hematopoietic Cells
    • 4.4.2.1. Hematopoietic cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Skin Cells
    • 4.4.3.1. Skin cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Hepatocytes
    • 4.4.4.1. Hepatocytes market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Gastrointestinal Cells
    • 4.4.5.1. Gastrointestinal cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.6. Lung Cells
    • 4.4.6.1. Lung cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.7. Renal Cells
    • 4.4.7.1. Renal cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.8. Heart Cells
    • 4.4.8.1. Heart cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.9. Skeletal and Muscle Cells
    • 4.4.9.1. Skeletal and muscle cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.10. Other Primary Cells
    • 4.4.10.1. Other primary cells market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Primary Cell Culture Media
  • 4.5.1. Global Primary Cell Culture Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Serum-free Media
    • 4.5.2.1. Global Serum-free Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Serum-containing Media
    • 4.5.3.1. Global Serum-contaning Media Market and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Other Media
    • 4.5.4.1. Global Other Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Reagents and Supplements
  • 4.6.1. Global Reagents and Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.2. Attachment Solutions
    • 4.6.2.1. Global Attachment Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.3. Buffers and Salts
    • 4.6.3.1. Global Buffers and Salts Market and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.4. Sera
    • 4.6.4.1. Global Sera Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.5. Growth Factors and Cytokines
    • 4.6.5.1. Global Growth Factors and Cytokines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.6. Others
    • 4.6.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Primary Cell Culture Market: Application Business Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global Human Primary Cell Culture Market Application, Movement Analysis
• 5.3. Global Human primary cell culture market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Drug Discovery
  • 5.4.1. Global Drug Discovery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Therapy Development
  • 5.5.1. Global Therapy Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Regenerative Medicine
  • 5.6.1. Global Regenerative Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Other Applications
  • 5.7.1. Global Other Applications Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Primary Cell Culture Market: End Use Business Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Global Human Primary Cell Culture Market End Use Movement Analysis
• 6.3. Global Human primary cell culture market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Pharmaceutical & Biotechnology Companies
  • 6.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. CMOs & CROs
  • 6.5.1. Global CMOs & CROs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Academic Research Institutes
  • 6.6.1. Global Academic Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Primary Cell Culture Market: Regional Estimates & Trend Analysis by Product, Application, and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. North America Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. U.S. Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Canada Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. Mexico Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. UK Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Germany Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. France Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Italy Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Spain Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. Denmark Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Framework
    • 7.4.8.4. Sweden Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Framework
    • 7.4.9.4. Norway Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Japan Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. China Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. India Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Australia Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Thailand Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. South Korea
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. South Korea Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Brazil Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Argentina Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. South Africa Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Saudi Arabia Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. UAE Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Kuwait Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Participant's Overview
  • 8.4.1. Thermo Fisher Scientific Inc.
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. STEMCELL Technologies
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Merck KGaA
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Lonza
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Cell Biologics, Inc.
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. PromoCell GMBH
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. ZenBio
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. AllCells
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. American Type Culture Collection
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. Axol Biosciences Ltd.
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives